SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

CAC 40 NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

OLAINFARM

Olainfarm Olainfarm

Olainfarm



Company : Olainfarm Compartment : Other
ISIN : LV0000100501 Wire : Thomson Reuters ONE
Document type : Permanent Information Releases / Notification of availability    
Publication date : 6/5/2019 8:01:00 PM    

Recording of the First Quarter 2019 Investor Conference Webinar

Recording of the First Quarter 2019 Investor Conference Webinar

On June 5 JSC Olainfarm organized its Investor Conference - Online Webinar. During the webinar the Chairman of Management Board Lauris Macijevskis, Member of the Supervisory Council Karlis Krastins and Investor Relations Advisor Janis Dubrovskis analyzed the financial results of first quarter 2019 and informed about other recent activities within the company.

The recorded webinar is available online: https://bit.ly/2Xq2Q3H, and the presentation, demonstrated during the webinar, is available in the attachment.

Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top -quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 60 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Additional information:       

Janis Dubrovskis
Investor Relations Advisor of JSC Olainfarm
Ph.: +371 29178878
janis.dubrovskis@olainfarm.com






Attachment

]]>

BACK TO THE LIST